Neogen Corporation
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-87.6% vs price
Base Case (Median)
-77.3% vs price
Bull Case (75th pct.)
-64.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $2.45 | -79.4% | High (40%) |
| EV/EBITDA | $7.86 | -33.8% | Medium (20%) |
| EV/FCF | $2.94 | -75.2% | Medium (20%) |
| Earnings Power Value | $-1.46 | -112.3% | Medium (50%) |
Based on 4 out of 8 methods, NEOG appears overvalued at the current price of $11.87. The base case fair value of $2.69 implies 77.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.